- Industry Solutions
Industry Solutions
From reshaping the quote to cash process, to transforming engagement with channels partners, to achieving excellence in global product launch, Model N enables digital reinvention with industry-specific solutions that maximize revenue.
- Right block
Contact Sales
Whitepaper
webinar
case-studies
whitepaper
Fill out the form to download this whitepaper
The Public Health Service Act 340B Drug Pricing Program enables providers that serve vulnerable patient populations to access outpatient drugs at significantly lower costs, which helps improve overall patient care. But for pharmaceutical manufacturers, program management can be extremely challenging.
Changes to the 340B program have led to an increase in the number of covered entities and contract pharmacies, as well as more stringent financial and legal implications for price errors.
For pharmaceutical manufacturers that participate in the 340B program, effective management of pricing, rebates, and chargebacks is crucial to protecting revenue streams and ensuring compliance. In this white paper, you’ll learn how you can improve your chargeback process, generate an audit trail, and ensure correct 340B pricing.
In this white paper we will:
- Discuss important changes to the 340B Drug Pricing Program.
- Provide best practices and practical approaches for streamlining 340B program management.
- Explain how you can reduce the risk of revenue leakage and noncompliance.
Some of our customers:
You might also be interested in
Preparing for Commercialization While You’re in Development
Learn how to position yourself in the market with innovative launch strategies and relationship building. VIEW webinar
Novartis and Model N: Partners in Revenue Management
Novartis has been a user of Model N’s revenue cloud for life sciences for over 15 years, as one of Model N’s founding clients. Over the years, Novartis has leveraged the Model N platform to automate pricing... VIEW case-studies
